A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vasoocclusive Crises
2022-11-21
عنوان الدراسة
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vasoocclusive Crises
داعم الدراسة
Global Blood Therapeutics, Inc.
دواء الدراسة
Inclacumab
رقم بروتوكول الدراسة
GBT2104-131
حالة الدراسة
Ongoing
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia , Qatif Central Hospital
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.